1. Ren, Chong, Pan, Runsang, Hou, Lisong, Tian, Xiaobin, Chen, Houping. 2020. Suppression of CLEC3A inhibits osteosarcoma cell proliferation and promotes their chemosensitivity through the AKT1/mTOR/HIF1α signaling pathway. In Molecular medicine reports, 21, 1739-1748. doi:10.3892/mmr.2020.10986. https://pubmed.ncbi.nlm.nih.gov/32319617/
2. Park, Ah Young, Han, Mi-Ryung, Seo, Bo Kyoung, Woo, Ok Hee, Park, Hyun Soo. 2023. MRI-based breast cancer radiogenomics using RNA profiling: association with subtypes in a single-center prospective study. In Breast cancer research : BCR, 25, 79. doi:10.1186/s13058-023-01668-7. https://pubmed.ncbi.nlm.nih.gov/37391754/
3. Janacova, Lucia, Stenckova, Michaela, Lapcik, Petr, Müller, Petr, Bouchal, Pavel. 2023. Catechol-O-methyl transferase suppresses cell invasion and interplays with MET signaling in estrogen dependent breast cancer. In Scientific reports, 13, 1285. doi:10.1038/s41598-023-28078-1. https://pubmed.ncbi.nlm.nih.gov/36690660/
4. Kaur, Dilraj, Arora, Chakit, Raghava, Gajendra Pal Singh. 2021. Prognostic Biomarker-Based Identification of Drugs for Managing the Treatment of Endometrial Cancer. In Molecular diagnosis & therapy, 25, 629-646. doi:10.1007/s40291-021-00539-1. https://pubmed.ncbi.nlm.nih.gov/34155607/